Doctors aim to crack the code on painful shoulder calcium deposits

NCT ID NCT07409818

First seen Feb 16, 2026 · Last updated Jun 23, 2026 · Updated 19 times

Summary

This study is developing a new way to classify calcium deposits in the shoulder using MRI scans. Researchers hope this system will help doctors decide whether to treat with medication, physical therapy, or surgery. The study will follow 400 patients for 12 months to see how different treatments work based on deposit location.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CALCIFIC TENDINITIS OF SHOULDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Koç University Hospital

    RECRUITING

    Istanbul, Zeytinburnu, 34010, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple MRI-based system that helps doctors choose the best treatment for shoulder calcific tendinitis.

What could go wrong

This is an observational study, not a treatment trial. The new classification may not improve outcomes or be adopted in practice.

Conditions

The condition(s) this trial relates to.

calcific tendinitis Rotator Cuff Tear Arthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.